Graeme Martin Currie's most recent trade in Pasithea Therapeutics Corp was a trade of 5,938 Stock Option (right to buy) done . Disclosure was reported to the exchange on March 1, 2024.
Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
---|---|---|---|---|---|---|---|---|---|---|
Pasithea Therapeutics Corp | Graeme Martin Currie | Chief Development Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Mar 2024 | 5,938 | 5,938 | - | - | Stock Option (right to buy) | |
Pasithea Therapeutics Corp | Graeme Martin Currie | Chief Development Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Mar 2024 | 5,938 | 5,938 | - | - | Stock Option (right to buy) |